MedTrace Logo

HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

NCT00600236 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-06-03

No results posted yet for this study

Summary

One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.

Conditions

  • Diabetes Mellitus Type 2
  • Proliferative Diabetic Retinopathy

Interventions

PROCEDURE

blood sample

Sponsors & Collaborators

  • Instituto Nacional de Referencia Epidemiológica (INdRE)

    collaborator UNKNOWN

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Hugo Quiroz-Mercado, MD · Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes"

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600236 on ClinicalTrials.gov